Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention

NCT07276763 · Not yet recruiting

Last updated 2026-05-28

This clinical trial is testing whether stopping GLP-1 receptor agonists for two weeks before an upper endoscopy affects the risk of delayed stomach emptying in people with gastric retention.

Status Not yet recruiting Approved but enrollment has not started.

Type Observational

Participants 16,509 people Planned (estimated).

Who can join all sexes

Timeline Started 2025-12 · est. completion 2025-12

Where 1 site · China

What this study is testing ClinicalTrials.gov NCT07276763 ↗

Description as written by the study sponsor.

A retrospective observational study to explore the impact of discontinuing GLP-1 receptor agonists for two weeks prior to upper endoscopy on the risk of gastric retention

Treatments tested

No Intervention: Observational Cohort Other

No Intervention: Observational Cohort

Main thing measured	Proportion of gastric retention
Sponsor	Fudan University
Conditions studied	Gastric Retention
GLP-1 drugs	—

Full protocol, eligibility, and contacts on ClinicalTrials.gov NCT07276763 ↗